Researchers have recently discovered a new type of embryonic airway cell that could revolutionize treatments for respiratory diseases. This newly discovered cell, known as “type II pneumocyte-like cells”, has the potential to support the repair and regeneration of airway tissue. These cells could be used to treat a variety of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. The team of experts believes that these type II pneumocyte-like cells could be a promising alternative to current treatments, which often have limited effectiveness. The researchers hope that this discovery could lead to new therapies for respiratory diseases and improve quality of life for those affected.

Read Full Article Here

source: Phys.org